Skip to main navigation Skip to search Skip to main content

Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial

  • Mark T. Gladwin
  • , Victor R. Gordeuk
  • , Payal C. Desai
  • , Caterina Minniti
  • , Enrico M. Novelli
  • , Claudia R. Morris
  • , Kenneth I. Ataga
  • , Laura De Castro
  • , Susanna A. Curtis
  • , Fuad El Rassi
  • , Hubert James Ford
  • , Thomas Harrington
  • , Elizabeth S. Klings
  • , Sophie Lanzkron
  • , Darla Liles
  • , Jane Little
  • , Alecia Nero
  • , Wally Smith
  • , James G. Taylor
  • , Ayanna Baptiste
    • Ward Hagar, Julie Kanter, Amy Kinzie, Temeia Martin, Amina Rafique, Marilyn J. Telen, Christina M. Lalama, Gregory J. Kato, Kaleab Z. Abebe

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science